Prodrugs
- 1 May 1985
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 29 (5) , 455-473
- https://doi.org/10.2165/00003495-198529050-00002
Abstract
Prodrugs are pharmacologically inactive chemical derivatives of a drug molecule that require a transformation within the body in order to release the active drug. They are designed to overcome pharmaceutical and/or pharmacokinetically based problems associated with the parent drug molecule that would otherwise limit the clinical usefulness of the drug. The scientific rationale, based on clinical, pharmaceutical and chemical experience, for the design of various currently used prodrugs is presented in this review. The examples presented are by no means comprehensive, but are representative of the different ways in which the prodrug approach has been used to enhance the clinical efficacy of various drug molecules.Keywords
This publication has 62 references indexed in Scilit:
- Prodrug designPharmacology & Therapeutics, 1981
- Pharmacokinetics of ampicillin and its prodrugs bacampicillin and pivampicillin in manJournal of Pharmacokinetics and Biopharmaceutics, 1979
- The Long-Acting Neuroleptics: A Retrospective AppraisalDrug Metabolism Reviews, 1978
- Pharmacokinetic Studies on Flupenthixol Decanoate, A Depot Neuroleptic of the Thioxanthene GroupDrug Metabolism Reviews, 1978
- Esters of 4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazineethanol and related compounds as long-acting antipsychotic agents. Synthesis of the 1-adamantoate, the first crystalline base. 4Journal of Medicinal Chemistry, 1977
- Rationale for Design of Biologically Reversible Drug Derivatives: ProdrugsJournal of Pharmaceutical Sciences, 1975
- Intramuscular Absorption of Drugs from Oily Solutions in the RatCHEMICAL & PHARMACEUTICAL BULLETIN, 1974
- Synthesis and Bioactivity of Lincomycin 2-MonoestersJournal of Pharmaceutical Sciences, 1973
- Relative Stability of Hetacillin and Ampicillin in SolutionJournal of Pharmaceutical Sciences, 1972
- Synthesis and Bioactivity of Lincomycin-2-PhosphateJournal of Pharmaceutical Sciences, 1969